Skip to main content
. Author manuscript; available in PMC: 2013 Dec 17.
Published in final edited form as: Gynecol Oncol. 2008 Apr 14;109(3):10.1016/j.ygyno.2008.02.028. doi: 10.1016/j.ygyno.2008.02.028

Fig. 1.

Fig. 1

Median time to progression. Kaplan–Meier plot of time to progression in patients treated with weekly topotecan. Dashed lines represent the 90% confidence interval. Tick marks on the Kaplan–Meier curve represent censored patients.